![Ronit Simantov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronit Simantov
Direttore Tecnico/Scientifico/R&S presso
GAMIDA CELL LTD.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Ronit Simantov currently works at TempestTx, Inc., as Director and Gamida Cell Ltd., as Chief Medical & Scientific Officer.
Dr. Simantov also formerly worked at Bayer HealthCare Pharmaceuticals, Inc., as Oncology Director in 2007, Clovis Oncology, Inc., as Independent Director from 2021 to 2023, Tempest Therapeutics, Inc., as Independent Director from 2021 to 2026, Pfizer Inc., as Head-Oncology Global Medical Affairs from 2011 to 2017, CuraGen Corp., as Chief Medical Officer from 2007 to 2009, and OSI Pharmaceuticals, Inc., as Vice President-Clinical Research from 2010 to 2011.
Dr. Simantov received her undergraduate degree from The Johns Hopkins University and doctorate degree from New York University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Ronit Simantov
| Società | Posizione | Inizio |
|---|---|---|
| GAMIDA CELL LTD. | Direttore Tecnico/Scientifico/R&S | 01/07/2017 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ronit Simantov
| Società | Posizione | Fine |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/05/2026 |
| CLOVIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 10/07/2023 |
| PFIZER INC. | Corporate Officer/Principal | 01/06/2017 |
| OSI PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2011 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/09/2009 |
Formazione di Ronit Simantov
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
